PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver.
about
PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
PEGylation of osteoprotegerin/ ...... ake into rats and human liver.
@en
PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor
@nl
type
label
PEGylation of osteoprotegerin/ ...... ake into rats and human liver.
@en
PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor
@nl
prefLabel
PEGylation of osteoprotegerin/ ...... ake into rats and human liver.
@en
PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor
@nl
P2093
P2860
P1476
PEGylation of osteoprotegerin/ ...... ake into rats and human liver.
@en
P2093
Akiko Okada
Atsushi Kurihara
Eisuke Tsuda
Fumihiko Okada
Juergen Mueller
Junichi Okada
Kazuki Yano
Masashi Honma
Motoko Saito-Yabe
Nao Fukuda
P2860
P304
P356
10.1111/J.2042-7158.2010.01120.X
P577
2010-08-01T00:00:00Z